ABVC BioPharma, Inc. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
ABVC BioPharma, Inc. (ABVC) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $3.87 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2026-03-03
- ABVC BioPharma, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2024 was $3.87K.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|
| 2024-12-31 | $3.87K 10-K · filed 2026-03-03 |